Cardiovascular Preventing Effects of Dipeptidyl Peptidase-4 Inhibitors: Beyond Glucagon-Like Peptide-1

被引：0
|
作者：
Wang, Xi-Mei
Yang, Yue-Jin
Wu, Yong-Jian
机构：
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 2012年 / 110卷 / 10期
关键词：
INFARCTION;
D O I：
10.1016/j.amjcard.2012.08.024
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1551 / 1551
页数：1
相关论文
共 50 条
  • [21] Risk of heart failure hospitalization among users of dipeptidyl peptidase-4 inhibitors compared to glucagon-like peptide-1 receptor agonists
    Dawwas, Ghadeer K.
    Smith, Steven M.
    Park, Haesuk
    CARDIOVASCULAR DIABETOLOGY, 2018, 17
  • [22] Risk of heart failure hospitalization among users of dipeptidyl peptidase-4 inhibitors compared to glucagon-like peptide-1 receptor agonists
    Ghadeer K. Dawwas
    Steven M. Smith
    Haesuk Park
    Cardiovascular Diabetology, 17
  • [23] RESHAPING DIABETES CARE: THE FUNDAMENTAL ROLE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS AND GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS IN CLINICAL PRACTICE
    Umpierrez, Guillermo E.
    Meneghini, Luigi
    ENDOCRINE PRACTICE, 2013, 19 (04) : 718 - 728
  • [24] Suppression of Food Intake by Glucagon-Like Peptide-1 Receptor Agonists: Relative Potencies and Role of Dipeptidyl Peptidase-4
    Jessen, Lene
    Aulinger, Benedikt A.
    Hassel, Jonathan L.
    Roy, Kyle J.
    Smith, Eric P.
    Greer, Todd M.
    Woods, Stephen C.
    Seeley, Randy J.
    D'Alessio, David A.
    ENDOCRINOLOGY, 2012, 153 (12) : 5735 - 5745
  • [25] THE EXPRESSION OF GLUCAGON-LIKE PEPTIDE-1 AND DIPEPTIDYL PEPTIDASE-4 IN SHRSP.Z-LEPR FA /IZMDMCR RATS
    Sugahama, Sari
    JOURNAL OF HYPERTENSION, 2016, 34 : E179 - E179
  • [26] Novel therapeutics for type 2 diabetes: Incretin hormone mimetics (glucagon-like peptide-1 receptor agonists) and dipeptidyl peptidase-4 inhibitors
    Verspohl, E. J.
    PHARMACOLOGY & THERAPEUTICS, 2009, 124 (01) : 113 - 138
  • [27] Comparative effects of glucagon-like peptide-1 receptors agonists, 4-dipeptidyl peptidase inhibitors, and metformin on metabolic syndrome
    Bouzas, Cristina
    Pastor, Rosario
    Garcia, Silvia
    Monserrat-Mesquida, Margalida
    Martinez-Gonzalez., Miguel Angel
    Salas-Salvado, Jordi
    Corella, Dolores
    Goday, Albert
    Martinez, J. Alfredo
    Alonso-Gomez, Angel M.
    Fernandez-Barcelo, Olga
    Vioque, Jesus
    Romaguera, Dora
    Lopez-Miranda, Jose
    Estruch, Ramon
    Tinahones, Francisco J.
    Lapetra, Jose
    Serra-Majema, Lluis
    Riquelme-Gallegop, Blanca
    Martin-Sanchez, Vicente
    Pinto, Xavier
    Delgado-Rodriguez, Miguel
    Matia, Pilar
    Vidal, Josep
    Cardenas-Salas, Jersy-Jair
    Daimiel, Lidia
    Ros, Emilio
    Toledo, Estefania
    Manzanares, Josep M.
    Gonzalez-Monge, Inmaculada
    Munoz, Miguel-Angel
    Martinez-Urbistondo, Diego
    Tojal-Sierra, Lucas
    Munoz-Bravoaf, Carlos
    Miralles-Gisbert, Salvador
    Martin, Marian
    Garcia-Rios, Antonio
    Castro-Barquero, Sara
    Fernandez-Garcia, Jose Carlos
    Santos-Lozano, Jose Manuel
    Basterra-Gortari, F. Javier
    Gutierrez-Carrasquilla, Liliana
    Guillem-Saiz, Patricia
    Satorres, Alba
    Abete, Itziar
    Sorto-Sanchez, Carolina
    Diez-Espino, Javier
    Babio, Nancy
    Fito, Montse
    Tur, Josep A.
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 161
  • [28] The efficacy and safety of dipeptidyl peptidase-4 inhibitors and glucagon-like peptide-1 agonists in pediatric patients with type 2 diabetes: a systematic review
    Li, Xinyi
    Sun, Tong
    Du, Xin
    Xie, Xiaohui
    Shi, Luwen
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2022, 35 (12): : 1457 - 1463
  • [29] Can glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors help in mitigating the risk of atrial fibrillation in patients with diabetes?
    Thotamgari, Sahith Reddy
    Grewal, Udhayvir Singh
    Sheth, Aakash R.
    Babbili, Akhilesh
    Dominic, Paari
    CARDIOVASCULAR ENDOCRINOLOGY & METABOLISM, 2022, 11 (03):
  • [30] Incretin-based Therapies (Glucagon-like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors) for the Treatment of Type 2 Diabetes
    Hanna, Amir
    Woo, Vincent
    Yale, Jean-Francois
    Cooke, Elaine M.
    CANADIAN JOURNAL OF DIABETES, 2012, 36 (01) : 9 - 14
12345